Mark Charles Walters, MO

Mark Walters practices at UCSF Benioff Children's Hospital Oakland in Oakland, California, part of University of California Health.

Mark Walters' NPI, 1588753610, was assigned on October 12, 2006. Mark Walters graduated from UC San Diego School of Medicine in 1985. Mark Walters holds California license G85406.

Mark Walters' primary practice is UCSF Benioff Children's Hospital Oakland, at 747 52nd Street, Oakland, CA 94609 in Alameda County. The practice phone is (510) 428-3000.

Mark Walters' primary practice is UCSF Benioff Children's Hospital Oakland in Oakland, California, part of University of California Health. The medical group on file is UCSF Medical Group. Dmand AI also links Mark Walters to 2 more medical groups and 1 school health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mark Walters practices, 2 sites in all. Vendor and product names are available with a free account.

Pediatric hematology-oncology is Mark Walters' primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Mark Walters is board certified in pediatric hematology-oncology by the American Board of Pediatrics. Dmand AI has Mark Walters' licenses on file in 8 states: California, Nevada, Kentucky, Massachusetts, Rhode Island, New Jersey, Pennsylvania and Washington.

Across all payers, Dmand AI patient panel data puts Mark Walters' median patient age at 22, with 31% women.

Mark Walters accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 86 papers to Mark Walters, published from 2002 to 2025. 2024 was the busiest year, with 4. The most frequent topics are Anemia, Sickle Cell, Hematopoietic Stem Cell Transplantation and Bone Marrow Transplantation. Mark Walters has published most often in Biol Blood Marrow Transplant. Mark Walters' most frequent co-authors are Lakshmanan Krishnamurti, MD, Mary Eapen, MD and Joanne Kurtzberg, MD.

Dmand AI links Mark Walters to 13 clinical trials, 8 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Anemia, Sickle Cell, Anemia, Hemolytic, Congenital and Anemia, Aplastic. Fred Hutchinson Cancer Center sponsors the most, 3.

CMS Open Payments shows 45 general payments to Mark Walters from 7 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 76% of the total. Vertex Pharmaceuticals Incorporated paid the most, $48,575.

Mark Walters graduated from UC San Diego School of Medicine in 1985.

Mark Walters is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.